HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

499.163

-20.886-4.02%

Number of Gainers:4

Number of Losers:27

Number of Flat:2

PE:- -

High:529.916

Open:520.357

Low:497.894

Close:520.049

Volume:109.12M

Turnover:2.94B

Market Cap:316.03B

Float Cap:282.74B

Loading ...

Ascletis Says ASC50 Cuts PASI Score 48.9% in 28-Day U.S. Plaque Psoriasis Study

Ascletis Pharma-B (01672) Reports Positive 28-Day Proof-of-Concept Clinical Results for First-in-Class and Best-in-Class Oral Small Molecule IL-17A Inhibitor ASC50 in Treating Plaque Psoriasis in the United States

Ascletis Announces Positive Results from 28-Day Proof-of-Concept Clinical Study in U.S. for Asc50, a First-in-Class and Best-in-Class Oral Small Molecule Il-17a Inhibitor for the Treatment of Plaque Psoriasis

THOMSON REUTERS

Ascentage Pharma Group International's Chairman Buys 38,630 Shares

Ascentage Pharma Group International - Chairman Buys 38,630 Shares for Hk$1.2 Mln at Hk$29.95 Per Share on Sept 23-25

THOMSON REUTERS

Mabwell's Subsidiary Lianwei Chuangyuan to Bring In Investors, Aiming to Boost Innovative Drug Business

Everest Medicines Forms ESG Committee

Pharma ETF Rebounds Against the Tide as Device Giants Provide Support, Defensive Strength Draws Attention

ALPHAMAB-B (09966) Repurchases 58,000 Shares for HK$465,000 on September 28

Gansu State Farms Pharmaceutical Alkali Factory and Guangzhou Anxin Pharmaceutical Discuss Collaboration

Antengene-B (06996) Repurchases 90,000 Shares for HK$303,300 on September 28

GenFleet-B (02595) Spends HK$3.1855 Million to Repurchase 116,000 Shares on September 28

Dezhan Healthcare's Subsidiary Receives FDA Approval for Clinical Trial of Innovative Drug WYY026B Injection

Healthcare Shows Resilience! Pharma ETF Huabao (562050) Rises Against the Market, Livzon Pharmaceutical Group Hits Limit Up! Medical Devices Show Localized Strength, Mindray and United Imaging Advance Together

Akeso Announces First Patient Enrolled in Global Phase Iii Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer

THOMSON REUTERS

ZYLOXTB Spends HK$1.1571 Million to Buy Back 54,000 Shares on September 25

EDDING GENOR Spends HK$6.8 Million to Repurchase 4 Million Shares on September 25

Model Companies Enter Biopharma: 2026 Becomes Pivotal Year for AI Drug Discovery

UBS Keeps "Buy" Rating on InnoCare Pharma with HK$21.80 Target Price

ZYLOXTB Spends HK$1.1571 Million to Buy Back 54,000 Shares on September 25

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BK1574/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":499.16254,"timestamp":1791446895366,"preClose":520.049,"halted":0,"volume":109118918,"delay":0,"changeRate":-0.040163,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-20.886475,"latestTime":"10-08 16:00:00","open":520.3571,"high":529.9157,"low":497.89404,"amount":2941270685.5,"amplitude":0.061574,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791509400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1791423000000,1791432000000],[1791435600000,1791446400000]],"pbRate":3.902555,"peRate":173.510034,"turnoverRate":0.004073,"increases":4,"decrements":27,"flats":1,"marketCap":316030602432,"floatMarketCap":282739169248},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":529.9157,"amplitude":0.061574,"preClose":520.049,"low":497.89404,"pbRate":"3.902555","latestPrice":499.16254,"volume":109118918,"delay":0,"open":520.3571,"prevYearClose":556.26263,"prevWeekClose":515.56,"prevMonthClose":532.388,"prevQuarterClose":532.388,"fiveDayClose":532.388,"twentyDayClose":512.388,"sixtyDayClose":525.18,"secType":"PLATE","market":"HK","turnoverRate":0.004073,"peRate":173.510034,"marketCap":316030602432,"floatMarketCap":282739169248,"timestamp":1791446895366,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":4,"down":27,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671265701","title":"Ascletis Says ASC50 Cuts PASI Score 48.9% in 28-Day U.S. Plaque Psoriasis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2671265701","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671265701?lang=en_us&edition=fundamental","pubTime":"2026-09-29 08:00","pubTimestamp":1790640030,"startTime":"0","endTime":"0","summary":"Ascletis says ASC50 cuts PASI score 48.9% in 28-day U.S. plaque psoriasis studyAscletis reported positive results from a 28-day U.S. proof-of-concept trial of ASC50 in plaque psoriasis.Results were pr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL4TYPnv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","01672","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108218509","title":"Ascletis Pharma-B (01672) Reports Positive 28-Day Proof-of-Concept Clinical Results for First-in-Class and Best-in-Class Oral Small Molecule IL-17A Inhibitor ASC50 in Treating Plaque Psoriasis in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=1108218509","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108218509?lang=en_us&edition=fundamental","pubTime":"2026-09-29 08:00","pubTimestamp":1790640027,"startTime":"0","endTime":"0","summary":"Ascletis Pharma-B (01672) announced positive results from a randomized, double-blind, placebo-controlled 28-day proof-of-concept clinical trial of ASC50 in patients with mild to moderate plaque...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK1515","01477","BK1574","BK1191","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671657252","title":"Ascletis Announces Positive Results from 28-Day Proof-of-Concept Clinical Study in U.S. for Asc50, a First-in-Class and Best-in-Class Oral Small Molecule Il-17a Inhibitor for the Treatment of Plaque Psoriasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2671657252","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671657252?lang=en_us&edition=fundamental","pubTime":"2026-09-29 08:00","pubTimestamp":1790640000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA8SGRHB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1574","01672","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670776256","title":"Ascentage Pharma Group International's Chairman Buys 38,630 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2670776256","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670776256?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:39","pubTimestamp":1790609952,"startTime":"0","endTime":"0","summary":"Sept 28 (Reuters) - Ascentage Pharma Group International <6855.HK>::*CHAIRMAN BUYS 38,630 SHARES FOR HK$1.2 MILLION AT HK$29.95 PER SHARE ON SEPT 23-25*Further company coverage: 6855.HK* ((Reuters.Bri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nRSD2LvJTj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06855","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670255226","title":"Ascentage Pharma Group International - Chairman Buys 38,630 Shares for Hk$1.2 Mln at Hk$29.95 Per Share on Sept 23-25","url":"https://stock-news.laohu8.com/highlight/detail?id=2670255226","media":"THOMSON REUTERS","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670255226?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:46","pubTimestamp":1790606775,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K0FO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1574","06855"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134119945","title":"Mabwell's Subsidiary Lianwei Chuangyuan to Bring In Investors, Aiming to Boost Innovative Drug Business","url":"https://stock-news.laohu8.com/highlight/detail?id=1134119945","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134119945?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:08","pubTimestamp":1790604493,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SH) has announced that, in line with its strategic development plan and to further advance its innovative drug business while focusing on technological...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","688062","BK1161","MEDX","159992","02493","BK0239","IBBQ","06978","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140049460","title":"Everest Medicines Forms ESG Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=1140049460","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140049460?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:06","pubTimestamp":1790604372,"startTime":"0","endTime":"0","summary":"Everest Medicines (01952) has announced the establishment of an Environmental, Social and Governance Committee, effective from September 28, 2026.The ESG Committee shall consist of no fewer than...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","01952","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119842469","title":"Pharma ETF Rebounds Against the Tide as Device Giants Provide Support, Defensive Strength Draws Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=1119842469","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119842469?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:55","pubTimestamp":1790596546,"startTime":"0","endTime":"0","summary":"On September 28, A-shares underwent a deep correction, yet the pharmaceutical sector once again demonstrated resilience, with the sector as a whole significantly outperforming the broader market,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","562050","09939","159938","512170","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194666412","title":"ALPHAMAB-B (09966) Repurchases 58,000 Shares for HK$465,000 on September 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1194666412","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194666412?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:28","pubTimestamp":1790594909,"startTime":"0","endTime":"0","summary":"ALPHAMAB-B (09966) announced that on September 28, 2026, it repurchased 58,000 shares for HK$465,000.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185291878","title":"Gansu State Farms Pharmaceutical Alkali Factory and Guangzhou Anxin Pharmaceutical Discuss Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=1185291878","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185291878?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:51","pubTimestamp":1790592684,"startTime":"0","endTime":"0","summary":"Recently, the core R&D team from Guangzhou Anxin Pharmaceutical Co., Ltd. visited the Pharmaceutical Alkali Factory Co., Ltd. for an on-site tour and discussion. The company's leadership team, along...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1515","BK1574","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180041245","title":"Antengene-B (06996) Repurchases 90,000 Shares for HK$303,300 on September 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1180041245","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180041245?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:20","pubTimestamp":1790590815,"startTime":"0","endTime":"0","summary":"Antengene-B (06996) has announced that on September 28, 2026, the company repurchased 90,000 shares for a total consideration of HK$303,300.For more major Hong Kong stock news, download the Zhitong...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","06996","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194011215","title":"GenFleet-B (02595) Spends HK$3.1855 Million to Repurchase 116,000 Shares on September 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1194011215","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194011215?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:00","pubTimestamp":1790589620,"startTime":"0","endTime":"0","summary":"GenFleet-B (02595) has announced that on September 28, 2026, it spent HK$3.1855 million to repurchase 116,000 shares.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","09939","02595","BK1161","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112995199","title":"Dezhan Healthcare's Subsidiary Receives FDA Approval for Clinical Trial of Innovative Drug WYY026B Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1112995199","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112995199?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:10","pubTimestamp":1790586629,"startTime":"0","endTime":"0","summary":"Dezhan Healthcare Company Limited (000813.SZ) has announced that its wholly-owned subsidiary, Beijing Honghui Xin Pharmaceutical Technology Co., Ltd., recently received notification from the U.S....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","MDTX","IBBQ","LNGR","159992","BK4588","BMED","06978","PSYK","BK0060","000813","BK4585","BK1161","MEDX","LABU","BK0239","BK1574","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132272624","title":"Healthcare Shows Resilience! Pharma ETF Huabao (562050) Rises Against the Market, Livzon Pharmaceutical Group Hits Limit Up! Medical Devices Show Localized Strength, Mindray and United Imaging Advance Together","url":"https://stock-news.laohu8.com/highlight/detail?id=1132272624","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132272624?lang=en_us&edition=fundamental","pubTime":"2026-09-28 13:22","pubTimestamp":1790572929,"startTime":"0","endTime":"0","summary":"On the first trading day after the Mid-Autumn Festival (September 28), A-shares underwent a deep correction, with the Shanghai Composite Index falling nearly 2% at one point. Pharmaceutical assets...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","000513","BK1583","BK1574","AGNG","159883","BK1515","BK0187","562050","RSPH","BK1100","159938","09996","LGHT","09939","BK0239","IEIH","HART","LNGR","PTH","MEDX","GDOC","BK0188","MDEV","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670400169","title":"Akeso Announces First Patient Enrolled in Global Phase Iii Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670400169","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670400169?lang=en_us&edition=fundamental","pubTime":"2026-09-28 10:05","pubTimestamp":1790561139,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUA2FCWX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2476274308.USD","LU0540923850.HKD","LU0561508036.HKD","LU1720050803.USD","LU1961090484.USD","LU0348767384.USD","LU2399975544.HKD","LU2778985437.USD","LU0348735423.USD","LU0417516738.SGD","BK1161","IE00B543WZ88.USD","BK1574","LU0417516571.SGD","LU0348766576.USD","KURE","LU2488822045.USD","LU2476274720.SGD","LU0634319403.HKD","IE00B5MMRT66.SGD","LU0348784397.USD","LU1794554557.SGD","IE00BPRC5H50.USD","09926","LU0348825331.USD","LU0348827113.USD","LU0417516902.SGD","LU0348783233.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196699729","title":"ZYLOXTB Spends HK$1.1571 Million to Buy Back 54,000 Shares on September 25","url":"https://stock-news.laohu8.com/highlight/detail?id=1196699729","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196699729?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:50","pubTimestamp":1790556615,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) has released an announcement stating that on September 25, 2026, the company spent HK$1.1571 million to repurchase 54,000 shares.The announcement disclosed the share buyback details, with the company allocating HK$1.1571 million for the repurchase of 54,000 shares on that date.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190","BK1583","BK1574","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121417907","title":"EDDING GENOR Spends HK$6.8 Million to Repurchase 4 Million Shares on September 25","url":"https://stock-news.laohu8.com/highlight/detail?id=1121417907","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121417907?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:40","pubTimestamp":1790556031,"startTime":"0","endTime":"0","summary":"EDDING GENOR (06998) has issued an announcement stating that on September 25, 2026, the company spent HK$6.8 million to repurchase 4 million shares, with a repurchase price of HK$1.695 to HK$1.7 per share.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","BK1161","06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192832662","title":"Model Companies Enter Biopharma: 2026 Becomes Pivotal Year for AI Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=1192832662","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192832662?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:21","pubTimestamp":1790554886,"startTime":"0","endTime":"0","summary":"On September 23, U.S. artificial intelligence startup Anthropic announced that its Claude model helped discover a new enzyme system, marking the first achievement of its biology research program.Just...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","399441","BK4588","BK1574","CHAT","VTHR","XBI","AIPO","ARTY","QTOC","BK4585","BK4581","BK1191","AGIX","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191016793","title":"UBS Keeps \"Buy\" Rating on InnoCare Pharma with HK$21.80 Target Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1191016793","media":"Deep News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191016793?lang=en_us&edition=fundamental","pubTime":"2026-09-27 12:30","pubTimestamp":1790483430,"startTime":"0","endTime":"0","summary":"UBS has released a research report maintaining its \"Buy\" rating and HK$21.80 target price for InnoCare Pharma (09969).InnoCare Pharma has entered into a collaboration with Eli Lilly (LLY.US) to...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688428","BK1574","EWH","09969","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187010326","title":"ZYLOXTB Spends HK$1.1571 Million to Buy Back 54,000 Shares on September 25","url":"https://stock-news.laohu8.com/highlight/detail?id=1187010326","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187010326?lang=en_us&edition=fundamental","pubTime":"2026-09-25 22:52","pubTimestamp":1790347940,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) has announced that on September 25, 2026, it spent HK$1.1571 million to repurchase 54,000 shares.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1100","BK1574","BK1587","02190"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":6,"totalSize":155,"code":"91000000","status":"200"}]}}